Table 3.
Predictors of outcome for Veno-Arterial ECMO patients.
| Variables | Survivors (n = 72) | Non-survivors (n = 113) | p-value |
|---|---|---|---|
| Age | 51.5 ± 15.1 | 55 ± 15.3 | 0.13 |
| BMI | 32.2 ± 8.9 | 31.2 ± 7 | 0.44 |
| SOFA score pre ECMO | 12.6 ± 1.9 | 14 ± 3.1 | <0.01 |
| Lactic acid pre ECMO | 6.6 ± 3.6 | 8.3 ± 5.6 | 0.03 |
| Predictors of outcome for Veno-Venous ECMO patients. | Variables | Survivors (n = 73) | Non-survivors (n = 42) | p-value |
|---|---|---|---|---|
| Age | 39 ± 13.3 | 49.8 ± 12.7 | <0.01 | |
| BMI | 35.8 ± 10.4 | 32.8 ± 9.5 | 0.12 | |
| SOFA score pre ECMO | 11 ± 3 | 2.2 ± 1.7 | 0.30 | |
| Lactic acid pre ECMO | 2.4 ± 1.9 | 2.2 ± 1.7 | 0.54 | |
| P/F ratio | 73.9 ± 33.2 | 64.9 ± 19.2 | 0.08 | |
| PEEP | 14 ± 5 | 15 ± 5 | 0.34 | |
| Pre ECMO ventilator days | 3.8 ± 5.3 | 4.3 ± 4.1 | 0.61 |
Data expressed as mean ± standard deviation. p values ≤ 0.05 were considered significant (in bold).
Age (years); BMI (kg/m2), body mass index; SOFA, sequential organ failure assessment; ECMO, extracorporeal membrane oxygenation; Lactic acid (mmol/L); P/F ratio, PaO2 to FiO2 ratio; PEEP (cmH2O), positive-end expiratory pressure.